Factors associated with palliative intervention utilization for metastatic renal cell carcinoma

2022 ◽  
Author(s):  
Hiren V. Patel ◽  
Sinae Kim ◽  
Arnav Srivastava ◽  
Brian M. Shinder ◽  
Joshua Sterling ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Factors Associated

Clinicopathologic factors associated with the development of sunitinib-induced hypertension (HTN) in patients (pts) with metastatic renal cell carcinoma (mRCC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e15551-e15551
Author(s):  
Victoria Neiman ◽  
Maya Gottfried ◽  
Hans J. Hammers ◽  
Mario A. Eisenberger ◽  
Michael Anthony Carducci ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Factors Associated ◽  
Induced Hypertension ◽  
Clinicopathologic Factors

Improvement of Medical Treatment in Japanese Patients With Metastatic Renal Cell Carcinoma

2022 ◽  
Vol 2 (1) ◽  
pp. 25-30
Author(s):  
RYO FUJIWARA ◽  
YOSHINOBU KOMAI ◽  
TOMOHIKO OGUCHI ◽  
NOBORU NUMAO ◽  
SHINYA YAMAMOTO ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Treatment Period ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Clinical Factors ◽  
First Line ◽  
Factors Associated ◽  
First Line Therapy ◽  
Line Therapy

Background/Aim: To evaluate the relationship between treatment period and overall survival (OS) and to identify clinical factors associated with OS in patients with metastatic renal cell carcinoma (mRCC). Patients and Methods: Two hundred thirteen consecutive patients with mRCC receiving systemic therapy between 2008 and 2020 were divided into two groups: those starting first-line therapy in 2008-2015 (n=133) and those in 2016-2020 (n=80). Clinical factors associated with OS were retrospectively and statistically analyzed. Results: Median OS and one-, three- and five-year OS rates were not reached and 88.7%, 64.9%, and 64.9% in patients treated in 2016-2020; 31.4 months and 78.5%, 42.8% and 34.2% in 2008-2015 (p=0.0013). Multivariate analysis identified the period in which first-line therapy was started as the strongest predictor for OS (p=0.0002). Conclusion: OS was significantly better in mRCC patients treated in 2016-2020 than in 2008-2015. Treatment period was the strongest predictor for OS.

Sociodemographic Factors Associated With Nephrectomy in Patients With Metastatic Renal Cell Carcinoma

2009 ◽  
Vol 181 (3) ◽  
pp. 1013-1019 ◽  
Author(s):  
Nicholas J. Hellenthal ◽  
Karim Chamie ◽  
Michelle L. Ramirez ◽  
Ralph W. deVere White
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Sociodemographic Factors ◽  
Factors Associated

scholarly journals Prognostic factors associated with the response to sunitinib in patients with metastatic renal cell carcinoma

2013 ◽  
Vol 20 (6) ◽  
pp. 546 ◽  
Author(s):  
I. Yildiz ◽  
F. Sen ◽  
L. Kilic ◽  
M. Ekenel ◽  
C. Ordu ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Factors Associated

scholarly journals Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma

2007 ◽  
Vol 18 (2) ◽  
pp. 249-255 ◽  
Author(s):  
T.K. Choueiri ◽  
B.I. Rini ◽  
J.A. Garcia ◽  
R.C. Baz ◽  
R.M. Abou-Jawde ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Prognostic Factors ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Term Survival ◽  
Long Term Survival ◽  
Factors Associated

scholarly journals Factors Associated with Palliative Care (PC) Utilization in Advanced and Metastatic Renal Cell Carcinoma (RCC)

2021 ◽  
Vol 233 (5) ◽  
pp. e230-e231
Author(s):  
Hiren V. Patel ◽  
Joshua Sterling ◽  
Arnav Srivastava ◽  
Biren Saraiya ◽  
Tina M. Mayer ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Palliative Care ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Factors Associated

1103: Laparoscopic Salvage Nephrectomy after Targeted Neoadjuvant Therapy for Metastatic Renal Cell Carcinoma: Initial Results

2007 ◽  
Vol 177 (4S) ◽  
pp. 364-364 ◽  
Author(s):  
Surena F. Matin ◽  
Christopher G. Wood ◽  
Shi-Ming Tu ◽  
Nizar M. Tannir ◽  
Eric Jonasch
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Neoadjuvant Therapy ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Initial Results
Sign in / Sign up

Export Citation Format

Share Document